Invex Therapeutics Ltd (ASX:IXC)
0.0930
-0.0020 (-2.11%)
Apr 16, 2026, 11:56 AM AEST
32.86% (1Y)
| Market Cap | 6.99M +25.7% |
| Revenue (ttm) | 229.08K -81.1% |
| Net Income | -835.92K |
| EPS | -0.01 |
| Shares Out | 75.15M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,619 |
| Average Volume | 26,132 |
| Open | 0.0950 |
| Previous Close | 0.0950 |
| Day's Range | 0.0930 - 0.0950 |
| 52-Week Range | 0.0740 - 0.1800 |
| Beta | 0.37 |
| RSI | 32.46 |
| Earnings Date | May 13, 2026 |